Grant A Challen1, Margaret A Goodell. 1. Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, Tex. 77030, USA.
Abstract
OBJECTIVE: RUNX1 (also known as acute myeloid leukemia 1) is an essential regulator of hematopoiesis and has multiple isoforms arising from differential splicing and utilization of two promoters. We hypothesized that the rare Runx1c isoform has a distinct role in hematopoietic stem cells (HSCs). MATERIALS AND METHODS: We have characterized the expression pattern of Runx1c in mouse embryos and human embryonic stem cell (hESC)-derived embryoid bodies using in situ hybridization and expression levels in mouse and human HSCs by real-time polymerase chain reaction. We then determined the functional effects of Runx1c using enforced retroviral overexpression in mouse HSCs. RESULTS: We observed differential expression profiles of RUNX1 isoforms during hematopoietic differentiation of hESCs. The RUNX1a and RUNX1b isoforms were expressed consistently throughout hematopoietic differentiation, whereas the RUNX1c isoform was only expressed at the time of emergence of definitive HSCs. RUNX1c was also expressed in the AGM region of E10.5 to E11.5 mouse embryos, the region where definitive HSCs arise. These observations suggested that the RUNX1c isoform may be important for the specification or function of definitive HSCs. However, using retroviral overexpression to study the effect of RUNX1 isoforms on HSCs in a gain-of-function system, no discernable functional difference could be identified between RUNX1 isoforms in mouse HSCs. Overexpression of both RUNX1b and RUNX1c induced quiescence in mouse HSCs in vitro and in vivo. CONCLUSIONS: Although the divergent expression profiles of Runx1 isoforms during development suggest specific roles for these proteins at different stages of HSC maturation, we could not detect an important functional distinction in adult mouse HSCs using our assay systems. 2010 ISEH-Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.
OBJECTIVE:RUNX1 (also known as acute myeloid leukemia 1) is an essential regulator of hematopoiesis and has multiple isoforms arising from differential splicing and utilization of two promoters. We hypothesized that the rare Runx1c isoform has a distinct role in hematopoietic stem cells (HSCs). MATERIALS AND METHODS: We have characterized the expression pattern of Runx1c in mouse embryos and human embryonic stem cell (hESC)-derived embryoid bodies using in situ hybridization and expression levels in mouse and humanHSCs by real-time polymerase chain reaction. We then determined the functional effects of Runx1c using enforced retroviral overexpression in mouseHSCs. RESULTS: We observed differential expression profiles of RUNX1 isoforms during hematopoietic differentiation of hESCs. The RUNX1a and RUNX1b isoforms were expressed consistently throughout hematopoietic differentiation, whereas the RUNX1c isoform was only expressed at the time of emergence of definitive HSCs. RUNX1c was also expressed in the AGM region of E10.5 to E11.5 mouse embryos, the region where definitive HSCs arise. These observations suggested that the RUNX1c isoform may be important for the specification or function of definitive HSCs. However, using retroviral overexpression to study the effect of RUNX1 isoforms on HSCs in a gain-of-function system, no discernable functional difference could be identified between RUNX1 isoforms in mouseHSCs. Overexpression of both RUNX1b and RUNX1c induced quiescence in mouseHSCs in vitro and in vivo. CONCLUSIONS: Although the divergent expression profiles of Runx1 isoforms during development suggest specific roles for these proteins at different stages of HSC maturation, we could not detect an important functional distinction in adult mouseHSCs using our assay systems. 2010 ISEH-Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.
Authors: H Miyoshi; M Ohira; K Shimizu; K Mitani; H Hirai; T Imai; K Yokoyama; E Soeda; M Ohki Journal: Nucleic Acids Res Date: 1995-07-25 Impact factor: 16.971
Authors: H Kotani; P B Newton; S Zhang; Y L Chiang; E Otto; L Weaver; R M Blaese; W F Anderson; G J McGarrity Journal: Hum Gene Ther Date: 1994-01 Impact factor: 5.695
Authors: Hui Huang; Andrew J Woo; Zachary Waldon; Yocheved Schindler; Tyler B Moran; Helen H Zhu; Gen-Sheng Feng; Hanno Steen; Alan B Cantor Journal: Genes Dev Date: 2012-07-03 Impact factor: 11.361
Authors: Jiehong Liao; Kyle E Hammerick; Grant A Challen; Margaret A Goodell; F Kurtis Kasper; Antonios G Mikos Journal: J Orthop Res Date: 2011-04-14 Impact factor: 3.494
Authors: Dan Ran; Kentson Lam; Wei-Jong Shia; Miao-Chia Lo; Jun-Bao Fan; David A Knorr; Patrick I Ferrell; Zhaohui Ye; Ming Yan; Linzhao Cheng; Dan S Kaufman; Dong-Er Zhang Journal: Blood Date: 2013-06-27 Impact factor: 22.113
Authors: Godfrey Grech; Joel Pollacco; Mark Portelli; Keith Sacco; Shawn Baldacchino; Justine Grixti; Christian Saliba Journal: Int J Hematol Date: 2013-12-01 Impact factor: 2.490
Authors: Dan Ran; Wei-Jong Shia; Miao-Chia Lo; Jun-Bao Fan; David A Knorr; Patrick I Ferrell; Zhaohui Ye; Ming Yan; Linzhao Cheng; Dan S Kaufman; Dong-Er Zhang Journal: Blood Date: 2013-01-31 Impact factor: 22.113